Greenwich LifeSciences Inc. (GLSI): Price and Financial Metrics

Greenwich LifeSciences Inc. (GLSI): $12.69

0.62 (+5.14%)

POWR Rating

Component Grades








Add GLSI to Watchlist
Sign Up

GLSI Price/Volume Stats

Current price $12.69 52-week high $21.44
Prev. close $12.07 52-week low $7.58
Day low $11.38 Volume 73,640
Day high $13.25 Avg. volume 46,069
50-day MA $15.06 Dividend yield N/A
200-day MA $10.99 Market Cap 163.42M

GLSI Stock Price Chart Interactive Chart >

Greenwich LifeSciences Inc. (GLSI) Company Bio

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

GLSI Latest News Stream

Event/Time News Detail
Loading, please wait...

GLSI Latest Social Stream

Loading social stream, please wait...

View Full GLSI Social Stream

Latest GLSI News From Around the Web

Below are the latest news stories about GREENWICH LIFESCIENCES INC that investors may wish to consider to help them evaluate GLSI as an investment opportunity.

Insiders hold 54% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI), and they've been buying recently

Key Insights Greenwich LifeSciences' significant insider ownership suggests inherent interests in company's expansion...

Yahoo | December 11, 2023

Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024

STAFFORD, Texas, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today announced that its Board of Directors has extended the lock-up of the shares owned by the Company’s directors, officers, and existing pre-IPO investors to December 31, 2024 which is approximatel

Yahoo | November 21, 2023

Greenwich LifeSciences Insiders Added US$653.7k Of Stock To Their Holdings

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...

Yahoo | November 14, 2023

Insider Buying: Snehal Patel Acquires 1,000 Shares of Greenwich LifeSciences Inc

On September 11, 2023, Snehal Patel, the CEO, CFO, and 10% Owner of Greenwich LifeSciences Inc (NASDAQ:GLSI), purchased 1,000 shares of the company.

Yahoo | September 13, 2023

We Think Greenwich LifeSciences (NASDAQ:GLSI) Can Afford To Drive Business Growth

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Yahoo | August 15, 2023

Read More 'GLSI' Stories Here

GLSI Price Returns

1-mo -35.32%
3-mo 46.20%
6-mo 59.62%
1-year 10.44%
3-year -65.17%
5-year N/A
YTD 20.63%
2023 -30.79%
2022 -37.53%
2021 -33.29%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!